FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Erythromycin Ointment
Status: Currently in Shortage
»Date first posted: 07/06/2022
»Therapeutic Categories: Ophthalmology; Pediatric

Expand all

Armas Pharmaceuticals Inc (Reverified 04/15/2024)

Company Contact Information:
732-637-1971

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Ointment, 0.5% 3.5-gram tubes (NDC 72485067035)	Available	Product is now available in wholesalers, distributors etc. Currently continuing to build inventory to supply market that have unmet needs
Ointment, 0.5% 1 -gram tube (NDC 72485067031)	Available	Product is now available in wholesalers, distributors etc. Currently continuing to build inventory to supply market that have unmet needs. Product is still available at Medigi and ANDA

Bausch & Lomb Incorporated (Reverified 04/15/2024)

Company Contact Information:
800-553-5340

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Erythromycin, Ointment, 5 mg/1 g (NDC 24208-910-19)	Limited Availability	Limited availability. Manufacturing and distribution is ongoing. Increase in demand orders will be taken on a case-by-case basis. CDC	Demand increase for the drug
Erythromycin, Ointment, 5 mg/1 g (NDC 24208-910-55)	Limited Availability	Limited availability. Manufacturing and distribution is ongoing. Increase in demand orders will be taken on a case-by-case basis. CDC	Demand increase for the drug

Fera Pharmaceuticals (Reverified 01/15/2024)

Company Contact Information:
516-277-1449

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Ointment, 5 mg/g (NDC 48102-057-11)	Limited quantities available	Dear Healthcare Provider Letter: Temporary Importation of Steri-Med Pharma, Inc.’s Erythromycin Ophthalmic Ointment 5mg/g to Address Drug Shortage (HYPERLINK)

Padagis US LLC (Reverified 04/01/2024)

Company Contact Information:
763-732-0225

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Ointment, 5 mg/1 g (NDC 0574-4024-39)	Unavailable	Currently out of stock. No estimated release date available. CDC	Discontinuation of the manufacture of the drug
Ointment, 5 mg/1 g (NDC 0574-4024-50)	Unavailable	Currently out of stock. No estimated release date available. CDC	Discontinuation of the manufacture of the drug
Ointment, 5 mg/1 g (NDC 0574-4024-35)	Unavailable	Currently out of stock. No estimated release date available. CDC	Discontinuation of the manufacture of the drug